These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 11257943)

  • 1. Antipsychotic medications for children and adolescents.
    Gracious BL; Findling RL
    Pediatr Ann; 2001 Mar; 30(3):138-45. PubMed ID: 11257943
    [No Abstract]   [Full Text] [Related]  

  • 2. Atypical neuroleptics in children and adolescents.
    Scahill L; Lynch KA
    J Child Adolesc Psychiatr Nurs; 1998; 11(1):38-43. PubMed ID: 9611543
    [No Abstract]   [Full Text] [Related]  

  • 3. Have the serotonin-dopamine antagonists rendered traditional antipsychotic agents obsolete?
    Goff DC
    Harv Rev Psychiatry; 1995; 3(2):101-3. PubMed ID: 9384935
    [No Abstract]   [Full Text] [Related]  

  • 4. [Risperidone].
    Zolk O; Thürauf N
    Dtsch Med Wochenschr; 2003 Jun; 128(24):1353-6. PubMed ID: 12802745
    [No Abstract]   [Full Text] [Related]  

  • 5. [Therapeutic gap when it comes to behavioral symptoms and psychoses among the elderly].
    Nygaard HA
    Tidsskr Nor Laegeforen; 2004 Oct; 124(19):2515. PubMed ID: 15477898
    [No Abstract]   [Full Text] [Related]  

  • 6. Current and novel approaches to the drug treatment of schizophrenia.
    Rowley M; Bristow LJ; Hutson PH
    J Med Chem; 2001 Feb; 44(4):477-501. PubMed ID: 11170639
    [No Abstract]   [Full Text] [Related]  

  • 7. The myth of the magic antipsychotic.
    Moncrieff J
    Ment Health Today; 2008 Jun; ():18-9, 22. PubMed ID: 18663800
    [No Abstract]   [Full Text] [Related]  

  • 8. Do loxapine plus cyproheptadine make an atypical antipsychotic? PET analysis of their dopamine D2 and serotonin2 receptor occupancy.
    Kapur S; Zipursky RB
    Arch Gen Psychiatry; 1998 Jul; 55(7):666-8. PubMed ID: 9672060
    [No Abstract]   [Full Text] [Related]  

  • 9. Behavioural pharmacology of 5-HT3 receptor antagonists: a critical update on therapeutic potential.
    Greenshaw AJ
    Trends Pharmacol Sci; 1993 Jul; 14(7):265-70. PubMed ID: 8105596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Iloperidone for schizophrenia.
    Rado J; Janicak PG
    Expert Opin Pharmacother; 2010 Aug; 11(12):2087-93. PubMed ID: 20586713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of antipsychotic medication in child and adolescent psychiatric treatment in Denmark. A cross-sectional survey.
    Deurell M; Weischer M; Pagsberg AK; Labianca J
    Nord J Psychiatry; 2008; 62(6):472-80. PubMed ID: 18841508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antipsychotic medications in children and adolescents.
    Findling RL; Grcevich SJ; Lopez I; Schulz SC
    J Clin Psychiatry; 1996; 57 Suppl 9():19-23. PubMed ID: 8823346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of antipsychotics in children and adolescents.
    Findling RL; Steiner H; Weller EB
    J Clin Psychiatry; 2005; 66 Suppl 7():29-40. PubMed ID: 16124839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-dose ziprasidone in treatment-resistant schizophrenia and affective spectrum disorders: a case series.
    Deutschman DA; Deutschman DH
    J Clin Psychopharmacol; 2007 Oct; 27(5):513-4. PubMed ID: 17873687
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment challenges and safety considerations for antipsychotic use in children and adolescents with psychoses.
    McConville BJ; Sorter MT
    J Clin Psychiatry; 2004; 65 Suppl 6():20-9. PubMed ID: 15104523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Current pharmacotherapy of schizophrenia].
    Bitter I
    Orv Hetil; 2004 Jan; 145(3):105-9. PubMed ID: 15027331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a novel program to facilitate monitoring physical health and adverse effects in children and adolescents prescribed antipsychotic medication.
    Ellis D; Shirzadi K; Grzeskowiak L; Angley M
    Australas Psychiatry; 2008 Oct; 16(5):368-9. PubMed ID: 18781460
    [No Abstract]   [Full Text] [Related]  

  • 18. Atypical antipsychotic agents in the treatment of Schizophrenia and other psychiatric disorders. Part II: Special considerations.
    J Clin Psychiatry; 1998 Jun; 59(6):322-8. PubMed ID: 9671350
    [No Abstract]   [Full Text] [Related]  

  • 19. Introduction. Ziprasidone in schizophrenia: from acute treatment to long-term management.
    Kane JM
    J Clin Psychiatry; 2003; 64 Suppl 19():3-5. PubMed ID: 14728083
    [No Abstract]   [Full Text] [Related]  

  • 20. Drug-drug interactions: Proof of relevance (Part II): cause of tolerability problems or noncompliance.
    Preskorn SH
    J Psychiatr Pract; 2005 Nov; 11(6):397-401. PubMed ID: 16304508
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.